Abstract: The present disclosure discloses a soil moisture detection device and system. By providing with an outer shell and providing with a circuit board and a main control chip in the outer shell, an end of a substrate is clamp connection to the outer shell, an inner of the substrate is provided with at least two electrode pieces. Two electrode pieces are facing to each other and have a gap between herein. At the same time, each electrode piece is coated with a substrate material to form a capacitive structure, which can have a larger capacitance, according to a humidity change of the soil, it can generate a corresponding capacitance change more sensitively, thereby improving a measurement accuracy and benefiting to achieve a more precise control of environmental soil moisture.

Abstract: The present disclosure discloses a soil moisture detection device, a first pole and a second pole are set in soil, a power supply switch circuit is controlled through a main control chip, an external voltage is added to a signal oscillation source, voltage is converted into an oscillation signal by the signal oscillation source, oscillation signal reaches a first pole through a first capacitor and a first inductor. When the soil between the first pole and second pole is completely dry, the two are equivalent to an open circuit, and a waveform detection unit can collect strong oscillation signal corresponding to frequency. When the soil between the first pole and second pole is moist, the oscillation signal is transmitted from the first pole to the second pole through the moist soil, an intensity of the oscillation signal corresponding to the frequency collected by the waveform detection unit changes.

Abstract: The present disclosure relates to certain macrocyclic compounds that inhibit SRC and MET, and/or CSF1R, pharmaceutical compositions containing such compounds, and methods of using such compounds to treat cancer.

Abstract: The present disclosure relates to certain macrocyclic compounds that inhibit SRC and MET, and/or CSF1R, pharmaceutical compositions containing such compounds, and methods of using such compounds to treat cancer.

Abstract: This disclosure relates to the use of certain diaryl macrocycle compounds, specifically (7S13R)-11-fluoro-7,13-di-methyl-6,7,13,14-tetrahydro-1,15-ethenopyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one in the treatment of disease in mammals. This disclosure also relates to compositions including such compounds, and to methods of using such compositions in the treatment of diseases in mammals, especially in humans.

Abstract: The present disclosure relates to certain macrocyclic compounds that inhibit SRC and MET, and/or CSF1R, pharmaceutical compositions containing such compounds, and methods of using such compounds to treat cancer.

Abstract: An irrigation system that controls the irrigation operations based upon soil irrigation decisions and weather forecasts generated by specific meteorological data, including soil temperature, soil moisture, air temperature, air humidity, air pressure, and rainfall collected by different sensors. The system comprises an irrigation decision module, a soil decision module, an air factor decision module, a rainfall information sensor, an irrigation controller, and a mobile APP. The irrigation system uses low-power radio frequency networking technology to communicate between different modules and devices.

Abstract: This disclosure relates to the use of certain diaryl macrocycle compounds, specifically (7S13R)-11-fluoro-7,13-di-methyl-6,7,13,14-tetrahydro-1,15-ethenopyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one in the treatment of disease in mammals. This disclosure also relates to compositions including such compounds, and to methods of using such compositions in the treatment of diseases in mammals, especially in humans.

Abstract: The present disclosure relates to certain macrocyclic compounds that inhibit SRC and MET, and/or CSF1R, pharmaceutical compositions containing such compounds, and methods of using such compounds to treat cancer.

Abstract: The present disclosure relates to certain macrocyclic compounds that inhibit SRC and MET, and/or CSF1R, pharmaceutical compositions containing such compounds, and methods of using such compounds to treat cancer.

Abstract: The present disclosure relates to certain macrocyclic compounds that inhibit SRC and MET, and/or CSF1R, pharmaceutical compositions containing such compounds, and methods of using such compounds to treat cancer.

Abstract: The present invention provides a method and a device for iris recognition. By providing a sensing unit under the iris recognition region of the display unit, the invention can capture the iris information of the user's eyeball in time, and then compare with the presetting iris information, and execute the operation instruction corresponding to the iris information, thereby effectively improving the precision of the iris recognition. In addition, the sensing unit is disposed under the display unit, and the overall thickness of the mobile device can be effectively reduced compared with the structure in which the camera is protruded and disposed independently outside the region of the display screen, so that the wearable device or the mobile device is thinner and more suitable for flexible wearable devices or mobile devices, to meet the needs of the market.

Abstract: This disclosure relates to the use of certain diaryl macrocycle compounds, specifically (7S13R)-11-fluoro-7,13-di-methyl-6,7,13,14-tetrahydro-1,15-ethenopyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one in the treatment of disease in mammals. This disclosure also relates to compositions including such compounds, and to methods of using such compositions in the treatment of diseases in mammals, especially in humans.

Abstract: Disclosed are a permanent magnet linear motor and a linear vibrator, the linear vibrator includes the permanent magnet linear motor, the permanent magnet linear motor includes a stator component, a rotor component and a motor housing (6), the stator component and the rotor component are both mounted in the motor housing (6), the rotor component includes a shaft (1), a supporter (9), and a permanent magnet (2), the supporter (9) is fixedly defined at the middle part of the shaft (1), the permanent magnet (2) is fixedly embedded in the supporter (9); the stator component includes a stator core (4), a frame (11), and a coil winding (8), the stator core (4) is fixedly defined in the motor housing (6), the frame (11) is formed by defining tooth structure on the stator core (4) along a radial direction, the coil winding (8) is coiled on the frame (11).

Abstract: The present disclosure relates to certain macrocyclic compounds that inhibit SRC and MET, and/or CSF1R, pharmaceutical compositions containing such compounds, and methods of using such compounds to treat cancer.

Abstract: Disclosed are a permanent magnet linear motor and a linear vibrator, the linear vibrator includes the permanent magnet linear motor, the permanent magnet linear motor includes a stator component, a rotor component and a motor housing (6), the stator component and the rotor component are both mounted in the motor housing (6), the rotor component includes a shaft (1), a supporter (9), and a permanent magnet (2), the supporter (9) is fixedly defined at the middle part of the shaft (1), the permanent magnet (2) is fixedly embedded in the supporter (9); the stator component includes a stator core (4), a frame (11), and a coil winding (8), the stator core (4) is fixedly defined in the motor housing (6), the frame (11) is formed by defining tooth structure on the stator core (4) along a radial direction, the coil winding (8) is coiled on the frame (11).

Abstract: This disclosure relates to the use of certain diaryl macrocycle compounds, specifically (7S13R)-11-fluoro-7,13-di-methyl-6,7,13,14-tetrahydro-1,15-ethenopyrazolo [4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one in the treatment of disease in mammals. This disclosure also relates to compositions including such compounds, and to methods of using such compositions in the treatment of diseases in mammals, especially in humans.